3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Cervical Carcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Gastric Cancer With Liver Metastases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
pembrolizumab
2
tremelimumab
1
poly ICLC
1
lenvatinib
1
durvalumab
1
balstilimab
1
Peptides
1
Pemetrexed
1
Carboplatin
1
Blood Specimen Collection
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Immunotherapy
×
30 days
×
Clear all
No trials found.